ATE155787T1 - Heteroatome enthaltende tricyclische verbindungen - Google Patents

Heteroatome enthaltende tricyclische verbindungen

Info

Publication number
ATE155787T1
ATE155787T1 AT93810325T AT93810325T ATE155787T1 AT E155787 T1 ATE155787 T1 AT E155787T1 AT 93810325 T AT93810325 T AT 93810325T AT 93810325 T AT93810325 T AT 93810325T AT E155787 T1 ATE155787 T1 AT E155787T1
Authority
AT
Austria
Prior art keywords
compounds containing
containing heteroatoms
tricyclic compounds
various
immunosuppressant
Prior art date
Application number
AT93810325T
Other languages
English (en)
Inventor
Karl Baumann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE155787T1 publication Critical patent/ATE155787T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
AT93810325T 1992-05-07 1993-05-04 Heteroatome enthaltende tricyclische verbindungen ATE155787T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (1)

Publication Number Publication Date
ATE155787T1 true ATE155787T1 (de) 1997-08-15

Family

ID=26300836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93810325T ATE155787T1 (de) 1992-05-07 1993-05-04 Heteroatome enthaltende tricyclische verbindungen

Country Status (25)

Country Link
US (1) US5514685A (de)
EP (1) EP0569337B1 (de)
JP (1) JP2788392B2 (de)
KR (1) KR100292311B1 (de)
CN (1) CN1037773C (de)
AT (1) ATE155787T1 (de)
AU (1) AU668152B2 (de)
CA (1) CA2095659C (de)
CY (1) CY2126B1 (de)
CZ (1) CZ291773B6 (de)
DE (1) DE69312386T2 (de)
DK (1) DK0569337T3 (de)
ES (1) ES2105193T3 (de)
FI (2) FI982476A0 (de)
GR (1) GR3024754T3 (de)
HU (2) HUT66531A (de)
IL (1) IL105607A (de)
MY (1) MY109602A (de)
NO (1) NO305865B1 (de)
NZ (1) NZ247553A (de)
PH (1) PH30456A (de)
RU (1) RU2126009C1 (de)
SG (1) SG47011A1 (de)
SK (1) SK282061B6 (de)
TW (1) TW330936B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
DK0786986T3 (da) 1994-10-26 2002-04-29 Novartis Ag Anvendelse af en umættet fedtalkohol
GB9421613D0 (en) * 1994-10-26 1994-12-14 Sandoz Ltd Organic compounds
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
AU749623B2 (en) 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
TR200003108T2 (tr) * 1998-04-27 2001-02-21 Fujisawa Pharmaceutical Co., Ltd. İlaç kompozisyonları
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
RU2206298C2 (ru) * 2000-09-22 2003-06-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ лечения глаукомы
CN101897662B (zh) 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
WO2011121105A1 (en) * 2010-04-02 2011-10-06 Tibotec Pharmaceuticals Macrocyclic integrase inhibitors
US10143682B2 (en) 2014-10-28 2018-12-04 Koushi Yamaguchi Medicine for improving state of pregnancy, and use thereof
AU2019318035A1 (en) 2018-08-10 2021-03-04 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship
CN113226331A (zh) 2018-12-18 2021-08-06 山口晃史 用于改善不孕不育症或妊娠状态的药物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives
US4952605A (en) * 1983-08-03 1990-08-28 The Regents Of The University Of California Manoalide analogs
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0364031B1 (de) * 1988-10-12 1992-12-23 Merck & Co. Inc. Verfahren zur Umlagerung von FK-506 unter Beteiligung von Hydroxid
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
JPH07108101B2 (ja) * 1989-02-28 1995-11-15 オ−クマ株式会社 リニアアクチュエータ駆動制御装置
WO1990015805A1 (en) * 1989-06-14 1990-12-27 Sandoz Ltd Heteroatoms-containing tricyclic compounds
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
US5384316A (en) * 1990-08-18 1995-01-24 Fisons Plc 4,16-diazatetracyclo[23.3.1.1.Hu 14,17=b . 0 Hu 4,9 triaconta-16,19-diene-2,3,10-trione derivatives
EP0480623A1 (de) * 1990-10-11 1992-04-15 Merck & Co. Inc. Halomakrolide und Derivate mit immunosuppressiver Wirkung
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
JP3644957B2 (ja) * 1991-09-05 2005-05-11 アボット・ラボラトリーズ 大環式イムノモジュレーター

Also Published As

Publication number Publication date
KR100292311B1 (ko) 2001-09-17
PH30456A (en) 1997-05-28
DE69312386T2 (de) 1998-01-29
HU211135A9 (en) 1995-10-30
JPH0641144A (ja) 1994-02-15
SK282061B6 (sk) 2001-10-08
IL105607A (en) 1998-01-04
CA2095659C (en) 2005-08-09
CZ291773B6 (cs) 2003-05-14
CN1037773C (zh) 1998-03-18
GR3024754T3 (en) 1997-12-31
HUT66531A (en) 1994-12-28
RU2126009C1 (ru) 1999-02-10
CY2126B1 (en) 2002-06-21
JP2788392B2 (ja) 1998-08-20
KR940005631A (ko) 1994-03-22
FI982476A7 (fi) 1998-11-16
HU9301190D0 (en) 1993-07-28
ES2105193T3 (es) 1997-10-16
SG47011A1 (en) 1998-03-20
US5514685A (en) 1996-05-07
FI102612B1 (fi) 1999-01-15
FI932035A0 (fi) 1993-05-05
MY109602A (en) 1997-03-31
AU668152B2 (en) 1996-04-26
NO931627L (no) 1993-11-08
FI102612B (fi) 1999-01-15
IL105607A0 (en) 1993-09-22
DE69312386D1 (de) 1997-08-28
EP0569337B1 (de) 1997-07-23
NO305865B1 (no) 1999-08-09
CN1083486A (zh) 1994-03-09
NZ247553A (en) 1995-07-26
AU3839393A (en) 1993-11-11
FI982476A0 (fi) 1998-11-16
CA2095659A1 (en) 1993-11-08
TW330936B (en) 1998-05-01
FI932035A7 (fi) 1993-11-08
EP0569337A1 (de) 1993-11-10
SK43593A3 (en) 1995-07-11
CZ82993A3 (en) 1994-01-19
NO931627D0 (no) 1993-05-05
DK0569337T3 (da) 1998-01-19

Similar Documents

Publication Publication Date Title
DE69312386D1 (de) Heteroatome enthaltende tricyclische Verbindungen
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
PL300068A1 (en) 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
PL300062A1 (en) Novel 7-(substituted)-8-(substituted)-9-[(substituted glycil) amido]-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts and metal complex, pharmaceutical agent and veterinary agent
DE69433784D1 (de) 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline
DK0671933T3 (da) Hidtil ukendte anvendelser af IL-10
DE3574871D1 (de) Heterozyklische verbindungen enthaltende zusammensetzungen und ihre verwendung als herbizide.
HU9401582D0 (en) Maqcrolide tetrahydropyrane derivatives
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
TW221051B (de)
ES2138362T4 (es) Derivados de citisina con contenido de fosforo.
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
GEP19991792B (en) Substituted Propane-2-ol Derivatives, Process for Their Preparation, Pharmaceutical Composition and Process for Its Preparation
ATE180474T1 (de) Imidazol-derivate und ihre verwendung als agrochemische mittel
JPS57158754A (en) Improvement on organic compounds

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee